$6.00
0.284.9%
At close: Nov 13, 4:00 PM EST
Tevogen Inc
TVGNNASDAQ
Tevogen fell 72.6% from $20.86 to $5.72, behind the S&P 500's +12.3%. Its worst day was Jun 26 (−26.6%), and its low came Jul 20 at $3.89.
Nov 14, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.50 beat the $-3.00 estimate on $0.00 revenue.
0.0% · S&P 500 0.0%
Tevogen closed at its highest level of the year, 15.3% above where the year started.
Story events cover the past 12 months · Times ET
+9.6% · S&P 500 +0.7%
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced that its Board of Directors (the "Board") has approved a reverse stock split of its common stock at a ratio of 50…
−24.8% · S&P 500 +0.7%
EPS of $-2.10 beat the $-2.50 estimate on $0.00 revenue.
−0.9% · S&P 500 +0.8%
EPS of $-1.61 beat the $-2.50 estimate on $0.00 revenue.
+11.7% · S&P 500 −0.1%
Tevogen shares fell 26.6%, while the S&P 500 fell 0.7%.
−26.6%, the year's worst day · S&P 500 −0.7%
Tevogen closed at its lowest level of the year, 81.3% below where the year started.
−7.6% · S&P 500 −0.2%
EPS of $-1.52 beat the $-2.50 estimate on $0.00 revenue.
−4.2% · S&P 500 −0.5%
Where it ended: a close of $5.72 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 27, 2026.
Nothing in the past 12 months.
All TVGN dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TVGN and SPY from Benzinga historical bars. Not investment advice.
